Introduction & Objectives: Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) continue to present a significant disease burden. The morbidity associated with traditional transurethral resection of the prostate (TURP) has led to the development of alternative energy sources, in an attempt to overcome some of these. Early reports of aquablation (water jet-based prostate resection) for lower urinary tract symptoms due to benign prostatic hyperplasia suggest efficacy similar to that of TURP. We present the two-year results of an ongoing trial. Methods: A prospective single-arm trial at three centres in Australia and New Zealand with 2-year follow-up. Participants were men aged 50-80 years with moderate-to-severe LUTS as determined by urodynamics. All patients underwentIntroduction & Objectives: Trial of voids (TOVs) consume a significant amount of healthcare time and resources. It is common practice to ask a patient to perform a series of voids following removal of a urinary catheter. This information is used to determine whether a TOV has been deemed successful. We aimed to develop a simple nomogram that can be used to predict the outcome of TOV using voided volume (V Vol ) and post-void residual (R Vol ) of the patient's first void. Methods: We retrospectively examined the results of all TOVs between May 2015 and June 2016 in a nurse lead urology outpatient TOV clinic. We recorded reason for catheterization, patient demographics, number of voids and V Vol and R Vol for all recorded voids. Results: A total of 186 patients with completed data were included in this study.
Reasons for catheterisation included acute urinary retention (n = 73), post urethral dilatation (n = 20), post radical prostatectomy (n = 30), other urological surgery (n = 35) and post transurethral resection of prostate with catheter on discharge (n = 28). A total of 12 females and 174 males were included in this study. We identified 7 patients that represented to our hospital within 7 days requiring recatheterisation. Voided volume was plotted against residual volume (Figure 1 ). Data was analysed to determine graph equations to predict 100% fail and pass rates. We have devised a simple nomogram that could be used clinically. Plotting values using the formula V Vol -R Vol , outcome of TOV can be predicted as pass (>100 mL), equivocal (À300 mL to 100 mL) and fail (<-300 mL). Conclusions: Streamlining of the TOV clinical pathway may be possible by examining first void data. We will be testing the above nomogram on prospectively collected data to validate our data. A clinical trial where patients that are predicted to pass and discharged after a single void is proposed. Those patients that are equivocal or predicted to fail are to continue a standard multi-void TOV. This simple nomogram could potentially decrease the burden of TOVs on healthcare systems.
Figure 1. Plot of voided volume versus residual volume
Introduction & Objectives: We reviewed the initial oncologic outcomes of prostate cancer incidentally diagnosed at the time of holmium laser enucleation of prostate (HoLEP). Methods: Institutional prospectively maintained HoLEP database was searched. All patient records with incidental prostate cancer at HoLEP were reviewed. Demographics and early oncological data were collected. Results: 1876 patients underwent HoLEP from 1999 -2015. 136 (7.2%) patients had incidental prostate cancer diagnosed at HoLEP. Median preoperative PSA of prostate cancer patients was 4.5 ng/ml. 32 patients (24%) underwent prior prostate biopsy of which 1 was ASAP (0.7%) and the rest were negative. On HoLEP histology analysis 107 (79%) of patients had low grade cancer Gleason ≤ 6, 17 (12%) had intermediate Gleason 7, and 12 (9%) had high grade Gleason 8-10 disease.
Management data was available for 49 (36%) patients. Treatment included surveillance in 31 patients (63%), radical prostatectomy in 8 (16%), radiation therapy in 8 (16%), and immediate androgen deprivation (ADT) in 2 patients (4%). Initial outcomes are detailed in Table 1 .
Median follow up of the entire cohort was 55 months (range 1-176 months). Biochemical recurrence free rate in the radical prostatectomy group was 88% at last follow-up. For the radiotherapy group, 25% failed treatment per Phoenix criteria although none have progressed clinically. Overall prostate cancer specific mortality for the entire cohort was 1.5% (2 patients). Conclusions: Prostate cancer is infrequently detected at HoLEP with predominantly low grade disease. Observation appears to be an acceptable management option, at least initially. Radical prostatectomy and radiotherapy for selected patients demonstrate encouraging early oncological outcomes with limited follow up.
Introduction & Objectives: Percutaneous nephrolithotomy (PCNL) is the recommended treatment for large renal stones. There has been debate about the various positions PCNL can be performed but little detail about costings. We aimed to compare the cost effectiveness of a modified supine position with traditional prone PCNL in Victoria, Australia. Methods: A group of 205 renal units (198 patients) were followed prospectively from two Victorian tertiary hospitals, with 76 operations performed in the prone position and 129 performed in the modified supine position. Data collected included time in theatre, time in recovery, length of stay in hospital, disposable costs and complications. Costing was calculated using a previously authenticated "bottom-up", allinclusive framework that generated perhour theatre, recovery unit and ward costs from base and maintenance costs, including staff wages. PCNL-specific equipment used for each procedure was added to generate costing data. Chi-squared and T-tests were used for statistical analysis. Results: Significant difference in overall costing was documented. Modified supine group had lower total cost ($6424.29) compared to prone ($7494.79) (p = 0.007). This was largely attributed to lower operative costs ($4250.93 vs $5084 .29, p = 0.002), itself a reflection of shorter operating time, and lower ward costs ($533.55 vs $1130.20 , p < 0.001), representing a shorter hospital stay. Conclusions: This prospective study using comprehensive bottom-up cost-analysis methods found that modified supine has significantly lower costs compared to prone PCNL. With current literature divided on comparative treatment outcomes of prone vs modified supine PCNL, this data may make the modified supine approach more attractive to both hospital managers and clinicians.
Introduction & Objectives:
Previous studies have demonstrated the efficacy of intravesical botulinum toxin (IVBT) injection in women with idiopathic overactive bladder (IOAB) who have failed lifestyle and antimuscularinic therapies. This pilot-study Results: Seven women (median age 69, range 42 -73) with IOAB were identified and included in this study. All women had IOAB-wet and had failed behavioural and anti-muscularinic therapies. Median pre-treatment pad use was 6 per day (range 4 -8). All women received 200 IU of Botulinum toxin A by 20 intradetrusor injections avoiding the trigone. Five out of seven women (71%) were continent at 6 week follow-up. Of those who did not achieve continence, 100% experienced an improvement in their pad use (67% and 75% reduction respectively). One of these patients, who did not achieve complete continence, also experienced elevated PVR and recurrent UTI requiring regular selfcatheterisation in the early follow-up period. The improvements in continence post IVBT were maintained for a median duration of 6.0 months (range 3-13 months). Conclusions: IVBT is an effective treatment for IOAB-wet within the rural setting with an absolute continence rate of 71% being achieved in the study population. There was only one patient who required self-catherisation to manage elevated PVR post treatment. The study dose of 200 IU was shown to maintain its effectiveness for a median duration of 6.0 months which is longer than previous studies have demonstrated. Introduction: Flexible ureteroscopy is one of the greatest inventions in the field of endoscopic urology. It enables examination and treatment of the upper urinary tract. However, it requires frequent and costly repairs that prevent many health care providers from introducing this technology. The single-use device is the way to overcome that problem.
Objective: Is the single-use flexible ureteroscope performing as well as standard of care reusable instrument? Methods: The single-use ureteroscope (Lithovue â , Boston Scientific) and two reusable scopes (URV-F â , Olympus and Flex-Xc â , Karl Storz) were assessed. Angulation and irrigation fluid flow were examined first with an empty working channel and then with various instruments engaged:
• hydrophilic guide wire • hydrophilic tip wire • laser fiber (200 lm)
• basket (1.9Fr) • biopsy forceps (3Fr)
Results: Instruments decreased the angulation range and fluid flow. However it was still possible to bend tested devices to almost 180 degrees in every case, which should be enough to reach all kidney calyxes. Furthermore there were only slight differences in fluid flow in used scopes
Conclusions: This version of a single use disposable flexible ureteroscope offers similar technical specifics to multiple use flexible ureteroscopes in regard to range of flexion and extension, and also in regard to fluid flow rates. It is likely to find utility in aspects of endourologic practice depending upon pricing issues Urolithiasis treatment in Australia: the age of ureteroscopic intervention Introduction & Objectives: The incidence of urolithiasis is increasing in the Western population. Significant advances in ureteroscopy and stone fragmentation energy sources has resulted in a paradigm shift in urolithiasis management. We aimed to assess the current state of urolithiasis management in Australia over the last 15 years using population-based data. Introduction and Objectives: Genitourinary tract surgery has been evolving in the past years particularly the introduction of minimally invasive surgery such as laparoscopy as one of the options that can be offered to the patient. In the Philippines, retroperitoneoscopic approach has been less popular because of "smaller and limited working space", the urologist's unfamiliarity with the operative technique and steeper associated learning curve compared to transperitoneal approach. In this study, we evaluate and analyze the indications, perioperative and postoperative complications of different retroperitoneoscopic laparoscopic urologic surgery at East Avenue Medical Center. Methods: This is a descriptive, retrospective study of patients who underwent retroperitoneoscopic urologic surgery done at East Avenue Medical Center from July 2008 to July 2016. Results: There were 45 retroperitoneoscopic urologic surgeries performed from July 2008 to July 2016 at East Avenue Medical Center with median age of 50 years AE 13 (SD). Majority was male (56%). Most common diagnosis was renal cyst (26%). Most patients underwent laparoscopic marsupialization (27%).
The operating time, intraoperative blood loss and blood transfusion were dependent on the procedural difficulty. The mean operating time was 255 min (75-495 min) with highest average operating time of 350 min (270-460 min) during laparoscopic radical nephrectomy.
Average estimated blood loss was 100 cc (<50-2500) while actual blood loss was 1112 cc (10-2990) although it varied from each procedure from less than 50 ml for most marsupialization of renal cyst to 2500 for adrenalectomy of a 14 x 12 cm adrenal tumor.
Patients stayed for 4 days (1 to 9 days). The longest average length of hospital stay was 5 days for patients who underwent radical nephrectomy (3 to 8 days), partial nephrectomy (4 to 6 days) and adrenalectomy (3 to 6 days).
5 cases had conversion to open: laparoscopic simple nephrectomy (2), adrenalectomy (1), partial nephrectomy (1), and ureterolithotomy (1). A conversion was required, due to poor camera quality, dense adhesions and a large size of the mass (14 x 12 cm mass at the superior aspect of the left kidney).
Complications were observed in 13 cases (29%). One patient who underwent retroperitoneoscopic ureterolithotomy had Emergency DJ stent insertion on the 2nd post-operative day due to increase urine output per JP drain. Post-operative blood transfusion was necessary in 2 patients: radical nephrectomy (1) and the nephroureterectomy (1). Other complications were fever, cough, and numbness of both lower extremities and swelling of left hip. Conclusions: Despite lesser number of retroperitoneoscopic urologic surgery cases compared internationally, this study on laparoscopic retroperitoneal surgery for urologic conditions in our institution showed it to be safe, reproducible and an effective procedure for most types of upper urinary tract surgery. Compared to other studies, the length of hospital stay was comparable but the operative time was longer. Complications of retroperitoneoscopic urologic surgeries were few and predominantly minor and can be managed easily.
Validation of a renal papillary grading system for patients with nephrolithiasis
Introduction and Objectives: The endoscopic appearance of renal papillae in patients with nephrolithiasis varies widely. We recently introduced a papillary grading system designed to standardize and simplify description of the papillae. Papillary appearance may be able to help predict metabolic stone risk profile, risk of stone recurrence and need for subsequent treatment. In this study, blinded assessors graded papillae to validate the papillary grading system and its ability to differentiate various stone phenotypes. Methods: Four blinded investigators (3 experienced urologists and a basic scientist) graded 108 randomized papillae of patients with stone disease. Half of the patients had apatite stones on analysis and the rest had calcium oxalate stones. The grading system assessed four recurring abnormal papillary features: plugging, pitting, loss of contour and amount of Randall's plaque. Each papilla received a numerical grade from 0 to 2 reflecting the severity of disease for each measured domain. Grading scores from the four domains were added up to a sum total (range 0-8). Weighted kappa statistics were used to determine intra and interobserver reliability between assessors. Results: Intra-observer reliability was extremely good across all four domains with Cohen's kappa (j) ranging from 0.75 to 0.99. Inter-observer reliability was excellent for plugging (j=0.84) and Randall's plaque (j=0.68), less good for pitting (j=0.56) and poorest for loss of contour (j =0.40), although j of 0.40 still indicated moderate agreement between assessors. Highly significant score differences were observed between apatite stone formers and idiopathic (Randall's plaque-type) calcium oxalate stone formers (Figure 1 ). Apatite stone formers had higher plugging, pitting and loss of contour scores while calcium oxalate stone formers had higher Randall's plaque scores. Conclusions: Our proposed papillary grading system demonstrated good to excellent inter-and intra-observer reliability. Endoscopic papillary grading scores were significantly different between apatite and calcium oxalate stone formers. The endoscopic appearance of the renal papillae as measured by the papillary grading system used in this study may have implications in stratifying and managing renal stone patients.
Female/Neuro-urology Does a fully automated bladder diary increase patient compliance and data accuracy? Updated feasibility report and current research Introduction & Objectives: This pilot study compared data values on participant preference, compliance and ease of use of a fully automated bladder diary and traditional paper diary to assess the utility of this new technology. This presentation updates and validates previous findings and informs of current research. Methods: Healthy volunteers (>18 years) completed two voiding chart types over separate 24-hour periods. These included the electronic fully automated (iUFlow device) diary and a traditional paper diary. Patients were instructed to complete data entry contemporaneously and to add any missed urination or intake events retrospectively. Online surveys of preference and demographics were performed at commencement of study and after each diary type use. Results: 15 participants were included in the study, age range 22-59 years (mean 35 years). 93% of patients preferred the automated diary to the paper diary after use. Mean reported number of missed urination events was significantly lower with use of the automated diary (1.1 automated diary vs. 2.5 paper diary, p = 0.048, paired t-test) displaying higher patient compliance. Differences in missed oral intake recordings existed but did not reach statistical significance (p = 0.315, paired t-test). Participants took an average time of 13.7mins to perform the automated diary and 25.5 minutes for the paper diary, which was significantly greater (p = 0.005, paired t-test). Conclusions: The use of a fully automated bladder diary such as the iUFlow has the potential to increase patient compliance, data quality and decrease burden on patients and was preferred over traditional paper diaries in this cohort. Further studies are currently underway addressing the limitations of the feasibility study with new devices that are able to measure flow in a patient population. Quantifying pelvic muscle tone with functional studies to improve the diagnostic accuracy of Overactive Pelvic Floor Muscles (OPFM) Introduction & Objectives: To review the current terminology and diagnostic criteria of overactive pelvic floor muscles (OPFM), and identify its functional correlation with cystoscopic and fluoroscopic urodynamic studies (FUDS) including urethral pressure measurements. Methods: Patients refractory to conservative therapy including bladder retraining, medications and pelvic muscle exercises for a variety of gamut of storage and voiding disorders were evaluated. Prospective data for 201 patients across both genders who underwent flexible cystoscopy and urodynamics for LUTS refractory to conservative management between 1 Jan 2014-1 Jan 2016 was collected.
Factors studied included history of lower urinary tract symptoms, voiding patterns, physical examination, cystoscopic findings and functional studies, which maximum urethral closing pressure (MUCP). Results: 201 were patients recruited. 85 were diagnosed with OPFM based on clinical presentation and presence of pelvic floor tenderness on examination. Significant differences were noted on functional studies with FUDS and urethral pressure measurement. Subjects with pelvic floor tenderness were found to have a higher (MUCP) at 93.1 cmH20 compared to 80.6 cmH20 (p = 0.015). Conclusions: There are distinct characteristics of OPFM on clinical examination and functional studies, in particular MUCP. In patients refractory to conservative treatments, specific urodynamics tests are useful in sub-categorising patients. When OPFM is diagnosed, the impact on patient management is significant, and targeted intervention with pelvic floor physiotherapy is central in the multimodal approach of this complex condition. Results: 151 patients received a total of 192 treatments in a twelve month period. 31% were performed under local anaesthesia, 63% with sedation and 6% with general anaesthesia. The treatment number ranged from; 48 patients having their first treatment, to one patient having their fifteenth treatment. 100 units were used in 154 procedures and 200 units in 34 procedures, (4 with other doses). 84% of patients had idiopathic detrusor overactivity and 16% had neurogenic detrusor overactivity. 13 patients developed a urine infection requiring antibiotics in the post-operative period. 9 patients commenced intermittent selfcatheterisation following the procedure for symptomatic urinary retention, two of whom is was the intended outcome. 36 patients were already performing intermittent self-catheterisation prior to botulinum toxin therapy. 6 patients chose not to have repeat injection when due. Conclusions: The risks of symptomatic urine infection or retention requiring catheterisation are low. Ongoing follow up of patients is required to determine when to schedule their next treatment. The repetitive nature of onaBotulinumtoxinA intradetrusor injection is a unique treatment where repeat therapy is one indicator of success. By establishing this audit, data collected over time will indicate patients discontinuing therapy.
Introduction & Objectives: Renal cell carcinoma (RCC) is often detected incidentally and early. Surgical intervention is the established standard of care in those with localized T1a RCC. The goal of surgery is curative with the preservation of renal function but the risk of chronic kidney disease (CKD) increases after surgery. The aim of this study was to investigate pre-and post-surgery factors in a large, local and comprehensive population based cohort associated with poor renal function outcome in patients with T1a RCC. Methods: All patients with a new diagnosis of RCC in Queensland over a 24 month period between 2012 and 2013 were ascertained through the Queensland Cancer Registry (QCR). A research nurse abstracted data from the clinical records of these patients and returned their de-identified information to the research team. The current analyses were restricted to patients with T1a RCC who underwent radical or partial nephrectomy and who had a presurgery estimated glomerular filtration rate (eGFR) ≥ 60 mL/minute/1.73 m 2 . We used both univariate and multivariable logistic regression, to assess which socio-demographic, medical and surgical factors were significantly associated with a decline in renal function to eGFR <60 mL/minute/ 1.73 m 2 measured at 3-12 months postsurgery. Results: There were 340 T1a RCC patients who had a pre-operative eGFR of ≥ 60 mL/min/1.73 m 2 . At 3-12 months post-surgery, 108/340 (32%) developed new-onset eGFR of <60 mL/min/1.73 m 2 . On multivariable analysis, greater age (p < 0.001), radical nephrectomy (p < 0.001) and decreasing pre-surgery eGFR were significantly related to this. Pre-existing hypertension (p = 0.07) also had higher odds of developing post-surgery renal dysfunction but this association did not reach statistical significance. Conclusions: A substantial proportion of patients who underwent surgery for T1a RCC developed new onset CKD. Greater age, radical nephrectomy and decreasing pre-surgery eGFR were the factors significantly associated with greatest risk in the Queensland cohort.
Incidence and manifestations of nutcracker syndrome on CT imaging of 2070 consecutive patients Introduction & Objectives: Compression of the left renal vein between the aorta and the superior mesenteric artery is termed Nutcracker Syndrome. The phenomenon results in left renal venous hypertension, leading to left renal, gonadal and pelvic varices. While there is a wide range of clinical presentations, the literature to date reports macroscopic intermittent haematuria as the most common presenting symptom. The disorder is often missed during routine diagnostics and its incidence is likely underestimated. Methods: A total of 2070 abdominopelvic CT scans were performed on patients between September 2009 and September 2014. Inclusion criteria were all CTAP and CTIVP performed over this period, regardless of the clinical history or indication, with images analysed and formally reported by a single radiologist. Reports were analysed sequentially. Patients with evidence of nutcracker syndrome and associated phenomena were documented in detail. Patient reports positive for nutcracker phenomenon were analysed in terms of population characteristics, predominant presenting complaint or symptoms and radiological findings. Results: We found a total of 54 patients (54/2070, 2.61%) with evidence of nutcracker syndrome, with equal numbers of urological (27/54) and non-urological (27/ 54) referrals. Conclusions: Nutcracker Syndrome is likely to be underestimated in practice, with our results reflecting a relatively high incidence in a population of scanned patients of 1 in 38. Half of all patients with CT scans positive for the phenomenon initially presented with abdominal pain, with a much smaller percentage presenting with haematuria for investigation. This is in contrast to current literature citing haematuria often as the chief presenting complaint. It remains important however to suspect Nutcracker Syndrome in cases of persistent haematuria in the absence of a medical or surgical cause. Similarly, Nutcracker Syndrome needs to be assessed in cases of pelvic varices and left sided varicocoele. • 178 patients presented to our institution with traumatic renal injuries. Males consisted of 83.7% (n = 149) of the patients. Median age of all patients was 25 years old, with the highest incidence being in the 16-19 year old group (30.7%).
• 93.3% (n = 166) of patients were successfully managed conservatively. 2.8% (n = 5) patients required angioembolisation for complications of conservative management, 1.7% (n = 3) of patients had angiography without intervention. 9% (n = 16) patients required an emergency laparotomy for management of their trauma, of which 11 did not have operative management of their renal injury and were considered to have successful conservative management. This included one patient with a grade 5 vascular injury. 1.7% (n = 3) of patients required a nephrectomy, these patients all had grade 5 injuries. A further 1.1% (n = 2) of patients had repair of their renal injury without nephrectomy. 2 patients died as a result of their trauma prior to any intervention.
• The most common mechanism of injuries were motorbike and motor vehicle accidents accounting for 22.5% (n = 40) and 21.9% (n = 39) of all injuries respectively.
• The distribution of injury grade was 18% grade 1 (n = 32), 19.7% grade 2 (n = 35), 23% grade 3 (n = 41), 34.3% grade 4 (n = 61), 5% grade 5 (n = 9).
There were 22 complications related to conservative management. 12 ClavienDindo grade I-II complications, and 10 Clavien-Dindo grade III-IV complications. These consisted of UTI and sepsis, bleeding, and urinoma or pseudoaneurysm formation.
Conclusions:
The conservative management of renal trauma results in acceptable complication rates and very low nephrectomy rates in our institution.
Are current Australian treatment guidelines for epididymo-orchitis out of date: a five year review of epididymo-orchitis at a tertiary referral hospital Introduction & Objectives: Australian therapeutic guidelines currently recommend that all patients with epididymoorchitis between the ages of 16 to 35 years old should be empiricially treated for sexually acquired epididymo-orchitis. These recommendations are based on population studies that are more than 20 years old. The aim of this project is to review the cause and treatment of epididymo-orchitis in a modern Australian population and to ensure that the current guidelines are appropriate. Methods: We conducted a retrospective review of all patients above the age of 16 years presenting to our institution between 2010 to 2015 with a clinical diagnosis of epididymo-orchitis. We recorded patient demographics, investigations performed, antibiotic regiment used for management, and length of hospital stay. Results: A total 282 patients presented with a clinical diagnosis of epididymoorchitis. 40% (n = 112) of patients were in the younger age group (16-35 years old). 54% (n = 61) of these patients had a urine PCR test performed, of which 13% (n = 8) of the tests were positive for Chlamydia trachomatis, and none were positive for Neisseria gonnorrhoea. 82% of patients had urine MCS performed, 7% (n = 8) of total patients in the younger group grew Escherichia coli. 75% of patients had an ultrasound to help confirm the diagnosis. 60% (n = 170) of patients were in the older group (>35 years). 34% (n = 58) of men in this group had a urine PCR performed, of which 2 men were positive for C. trachomatis. Both of these men were 38 years of age. Urine MCS was performed in 90% (n = 153) of men, of which 35% (n = 54) of tests had positive growth for a known uropathogen. Ultrasound was performed on 88% (n = 150) of men to help confirm the diagnosis. Conclusions: Current Australian guidelines for the treatment of epididymo-orchitis in the 16 to 35 year old age are appropriate. An emphasis should be made on the follow up of urine MCS results as more than 7% of patients in this age group may be suffering from non-sexually acquired epididymo-orchitis. Additionally, consideration should be made to in investigating and treating men in the 36 to 40 year old group for sexually acquired epididymo-orchitis. Introduction & Objectives: The maintenance of optimal vision during laparoscopic and robotic surgery is crucial to preserving operative awareness and as a result operative efficiency and safety. Loss of vision is commonly caused by laparoscopic lens fogging (LLF) which has prompted the development of various techniques to prevent it and remove it once it has occurred. However, limited comparative evidence exists in contemporary literature and there still remains no consensus as to the singular superiority of the vast array of methods. Methods: A formal Preferred Reporting Items for Systematic Reviews and MetaAnalysis (PRISMA) was performed incorporating PubMed, Embase, Web of Science and Google Scholar. We applied no limit to publication year, article type or journal. Reference lists from publications were cross checked to ensure no articles were missed via our search criteria. Despite this limited original research and heterogenous outcome measures precluded meta-analytical assessment. Subsequently, all articles identified were included in the final review, critiqued by the authors and subsequently summarized. In addition, we performed a detailed investigation into the basic science behind the etiology of LLF. Results: Vision loss has a vast list of plausible causes which can be adequately elucidated by current scientific theory, however no authors to date have completely characterized the complexity of the problem in its entirety. There still remains a lack of consensus in superior methods, and comparative evidence still remains significantly limited. Robotic LLF has been particularly poorly addressed in current literature.
Basic science principles relate to dew point temperature, misting and convection loss of temperature via insufflators. The key to management given the dearth of evidence lies within addressing these three particulars. Conclusions: Obscured vision during minimally invasive surgery is a dangerous phenomenon, typically caused by LLF. The etiology of LLF despite the application of viable scientific theory has yet to be definitively proven in the in vivo environment. Common methods in the management of LLF have little evidence-based data to support their use. A multi-arm comparative in-vivo analysis is required to formally assess these commonly used techniques in both standard and robotic laparoscopes to address this problem, for the benefit of increased patient safety and increased operative efficiency. Methods: An innovative organization, developed by younger researchers interested in contributing to the wider academic audience was legitimized in 2016 with its first annual assembly at the USANZ ASM. Supported by senior medical staff, but run by its members, the organization aims to increase the statistical power and influence of research efforts though collaboration and broad access to institutional data at members' varied locations. This has been achieved via several avenues including the creation of a formal committee, a website, project sheets available to all members online and a formalized email account which answers questions, collates ideas for collaboration projects and ensures members are contemporaneously updated regarding opportunities and subsequent successes. Results: Since its inception several collaboration projects have been published in internationally acclaimed journals including The Journal of Urology, Prostate International and Current Opinion in Urology. YURO has been present at over 5 domestic and international conferences providing regular updates for members who are unable to attend and further increasing their access to the latest scientific developments with ease via social media. Currently, representatives from over 9 clinical sites including rural Victoria and New Zealand are involved with plans to expand into other states.
YURO's membership base has significantly grown and with the aid of senior members has welcomed multiple medical students who have utilised the organization to begin their first research project with the guidance and support of more experienced researchers.
The organization has made a concerted effort to incorporate social media and technology into its standard practice and is currently followed by an array of international and local stakeholders some of who have significant reputations in academic urology. This has also allowed members to effortlessly increase their ability to network. Conclusions: YURO is a new and innovative organization increasing collaboration between engaged and motivated individuals. It has to date provided a support network for younger researchers to improve overall quality of work, ease of access, and network opportunities whilst also supplying a forum for the exchange of ideas, questions and development concepts. We look forward to continuing to grow with the support of USANZ. That is, they are likely to be stationary series and thus revert to a previous trend or mean following external shocks. There was a lack of evidence that the series for CIS did not contain a unit root (p = 0.12) and hence shocks have a permanent effect on the mean of the series. (8), TURBT (5), bladder washout (2), penile biopsy (2), radical orchidectomy (4), TURP (1), removal of FB (2), removal of stent (4) stent change (3), diagnostic flexible cystoscopy (3), TUR prostatic abscess (2), SPC insertion (2), circumcision (2), TRUS and prostate biopsy (1), Urethral dilatation (4), BNI (1) and excision of scrotal SCC (2). Eight cases (11%) were carried out by a consultant with 62 cases (89%) performed by a trainee with direct consultant supervision. All cases were supported by urologically trained theatre staff. There were 4 recorded Clavien-Dindo I and II complications with 2 Clavien-Dindo III complications.
The introduction of the designated urological acute theatre has allowed supervised emergency Surgery to be carried out in a safe environment with appropriate consultant cover. All patients with non-infected stones had attempted primary ureteroscopy. Successful stone clearance was achieved in 85% of cases thus reducing the burden of stent related morbidity and impact on elective operating lists for staged stone surgery. Other semi-urgent procedures were also performed without affecting elective operating. This service allows patients to be fasted appropriately without the delays commonly associated with emergency list sessions. We feel that this new service offers significant benefit to patients, trainees and their trainers.
Predictors of delay to cystoscopy and receipt of investigations in patients with haematuria Introduction & Objectives: Haematuria is the commonest presenting symptom in bladder cancer. Despite this, most cases of haematuria are benign or idiopathic. However, this may lead to delayed or inadequate haematuria assessment, subsequently affecting bladder cancer management in some patients. We aimed to identify factors that impact on the timeliness and adequacy of haematuria evaluation. Methods: Using electronic medical records, we undertook a retrospective cohort study identifying patients who underwent cystoscopy for investigation of haematuria at Austin Health. Cystoscopic procedures occurring from 1 st January 2015 to 31 st December 2015 were identified. Data on patient demographics, smoking, anticoagulation, degree of haematuria and referring clinician were collected. Exclusion criteria included age <18 years, history of bladder/urinary tract/renal cancer and cystoscopy for indications other than haematuria. Primary outcome measures were 1) Time from GP referral to urology consultation 2) Time from urology consultation to cystoscopy and 3) Receipt of investigations in the 180 days prior to cystoscopy. Comparisons between risk factors were carried out using negative binomial regression for count outcomes and chi-square test for categorical outcomes. Results: Over the study period, 308 eligible cases (228 males, 80 females) were identified. 196 (64%) patients were referred from the general practice setting. Patients waited a median of 38 days from GP referral to urology consultation and 28 days from urology consultation to cystoscopy. The median time to urology consultation was 65 days for women and 33.5 days for men (p = 0.015). However, the observed difference between males and females was no longer statistically significant on multivariable regression and the only independent predictors of a shorter interval were macroscopic haematuria and suspicious imaging findings. No significant differences in recent investigations between genders were observed. Conclusions: Gender is not a significant predictor of delayed haematuria assessment or receipt of recent investigations. Patients with macroscopic haematuria are more likely to experience prompter review by urology. Younger patients and those not on anticoagulation received fewer recent investigations. More education is required to ensure that all patients, particularly younger ones without an obvious cause for haematuria, are evaluated appropriately.
The incidence of post transrectal ultrasound (TRUS) biopsy infections at a regional Australian tertiary health facility: antibiotic resistance is to blame S. SMITH and K. LOCKHART Townsville Hospital, Douglas, Australia Introduction & Objectives: Transrectal ultrasound (TRUS) biopsy remains a relatively common technique used in the diagnosis of prostate cancer. It is especially common within regional Australian facilities where operating theatre availability may be limited. Infection remains one of the most common complications post TRUS biopsy. A prophylactic course of antibiotics taken pre and post procedure is used to minimize this risk. With the emergence of multi resistant bacteria, the incidence of post TRUS infections is increasing. Multi-resistant Escherichia coli remains the most common bacteria responsible for TRUS related infections. This study was done to review the incidence of post TRUS infections at an Australian regional tertiary facility and examine the percentage of these infections caused by multidrug resistant bacteria. Methods: A retrospective analysis was performed including three hundred patients who had undergone a TRUS biopsy at the Townsville Hospital between 2009-2015. Patients charts were reviewed to assess if they had represented to the emergency department post TRUS biopsy with an associated infection. In patients with proven post TRUS infections, pathology was reviewed to determine the infection type (UTI and/or sepsis) as well as the responsible bacteria and any demonstrated antibiotic resistance. Results: Three hundred patients who underwent TRUS biopsy at the Townsville Hospital were included in the study. Of these, seven patients represented to the emergency department with a post procedure infection (2.3%). Of these, five patients had a confirmed UTI (1.6%) while two had sepsis confirmed by blood cultures (0.7%). Escherichia coli was the most common bacteria responsible for infections (4 out of 7 patients), followed by Enterococcus faecalis (2 out of 7 patients) and Extended spectrum beta lactamase producing bacteria (1 out of 7 patients). All responsible bacteria demonstrated multidrug resistance. Conclusions: Overall the incidence of infection post TRUS biopsy was seven out of three hundred (2.3%). Escherichia coli was the bacteria most associated with these infections. All bacteria responsible for post TRUS infections demonstrated multidrug resistance. Hence, despite efforts with prophylactic antibiotics, individuals with multidrug resistant bacteria are still at risk of post procedure infection. Given this, one should consider prescribing broad spectrum empirical antibiotics in individuals presenting with post TRUS infections until cultures and sensitivities are available to guide appropriate antibiotic management.
Hospital episode costs: a practical framework in a Victorian public hospital 
School of
Introduction & Objectives: Multiple models have been applied for cost analysis in the health care sector. Many lack reliability and have little supporting evidence. We have produced a novel costing model and used this to produce costs for cystoscopy, a common minor urological procedure that can be performed either in a day unit or operating theatre. Methods: We created a 'bottom-up' costing model to calculate the cost efficiency of elective cystoscopy (flexible cystoscopy vs. rigid cystoscopy). In the model we included theatre and recovery time, day-case cost, in-patient ward costs, detailed staff cost, building costs, utility costs, equipment costs and case specific costs. Results: Generic theatre costs were estimated at A$773.63/hour, recovery costs at A$274.27/hour, ward costs at A $405.98/day and day unit costs at A $353.46/session. The majority of the total cost occurred from staffing salaries: 91.69% in theatre, 80.59% in recovery, 88.22% on the ward and 87.01% on the day unit.
Flexible cystoscopy performed in main theatre vs as an outpatient procedure results in a doubling of the cost (A$725.57 vs A$340.69) and performing a general anaesthetic cystoscopy is three times the cost (A$1059.52) of a day unit flexible cystoscopy. Conclusions: The 'bottom up' model can be used as a reliable framework for calculating actual costs associated with public hospital procedures accounting for different local infra-structural costs and wage costs to calculate an hourly rate of procedural costs. Using this model, flexible cystoscopy in the outpatient setting is shown to be an economical procedure in comparison to cystoscopy performed in theatre.
Quality evaluation of educational content on YouTube videos regarding vasectomy procedure
Introduction & Objectives: Increasingly medical trainees are using novel ways to educate themselves in conjunction with hands-on teaching. YouTube is one resource used, however does not undergo any peer-reviewing process and so the quality of the content cannot always be assumed to be accurate. We aimed to determine the educational quality of YouTube vasectomy videos as teaching resource for urology trainees. Methods: YouTube was searched using search terms; "Vasectomy surgical procedure", "No scalpel vasectomy", "How to perform a vasectomy", "Vasectomy for doctors". The first 10 pages of videos for each search were screened by 2 assessors. We excluded videos that were animations, wrong topics, non-English and duplicates. Included videos were assessed for usefulness by devising a scoring system with a maximum score of 19. To assess content, we created an objective five-point major scoring criteria derived from AUA and EAU guidelines for a vasectomy procedure. Nine minor criteria relating to the aesthetic of the video were also devised. Videos were deemed useful if they met all five major criteria and a total score of 14 or more. Results: A total of 800 videos were screened, 30 unique videos met the inclusion criteria. The mean score was 13.1 (SD 2.3) and no videos scored full marks. 11 (37%) videos were deemed useful by our criteria, 19 (63%) were not useful. The useful videos had more views per day (64 vs 40), more likes per 100 views (9.8 vs. 8.6) and were longer (10.2 vs. 7.2 minutes) though no difference reached conventional significance (p > 0.05). Conclusions: YouTube is a vast resource for free online medical education, but only a small number of videos on vasectomy demonstrated an educational quality that would benefit a urology trainee. YouTube should be used as an adjunct educational aid, not a standalone resource.
Introduction & Objectives: Surgical factors including the timing of surgery and ischaemic time have been noted to influence renal transplantation. Surgical expertise is increasingly seen as an important factor due to advanced immunosuppressive regimens decreasing non-surgery graft losses and poor availability of donor kidneys. Recent emphasis on systems-based approaches to patient safety has led to several studies demonstrating worse outcomes associated with surgery at night.
1 Contributing factors to explain such outcomes include provider fatigue and lack of full available resources. The aim of this study was to determine whether renal transplant graft outcomes are influenced by surgical timing, donor organ features and ischaemic time at a large metropolitan hospital in Melbourne. Methods: A retrospective chart review of all cadaveric renal transplants at the Alfred Hospital, Melbourne was conducted between 2010 and 2015. Living donor transplants and combined renal / heart or renal / lung transplants were excluded. The primary outcomes were short term complications (within 30 days), long term complications (30 days to 1 year) and overall graft survival. Surgical factors analysed included patient demographics, donor kidney characteristics (number of arteries and veins, side of kidney, need for additional repair), cold ischaemic time, duration of surgery and timing of surgery (afterhours or inhours). Data was analysed on SPSS Version 22. Results: There were 101 cadaveric renal transplants at the Alfred between 2010 and 2015. The median cold ischaemic time was 12 hours. Median anastomosis time was 1 hour. 65% of patients were operated on afterhours (defined as between 7 pm to 6am). The median length of stay was 8 days. 26% of patients had a long term surgical complication with the majority of these between ureteric strictures, lymphocoele and rejection. Afterhours operating was associated with a higher risk of long term complications (OR 4.092, 95%CI 1.283 to 13.045, p-value 0.02). There was no statistically significant association between cold ischaemic time and complication rate. Conclusions: Afterhours operating is associated with long term surgical complications. Delaying transplantation until the daytime may be worthwhile at the expense of increasing cold ischaemic time. When 'best judgement' was used 1 patient (3.4%) of patients had a malpositioned JJ stent. Cystoscopy found 100% of malpositioned JJ stents. Amongst those who underwent artificial bladder filling, vesico-ureteric reflux was confirmed intra-operatively in 18 (94.5%). In the single patient where reflux was absent, the JJ stent was repositioned until reflux was observed. Additionally, one (5.3%) patient who underwent artificial bladder filling had intra-ureteric stent malposition identified at the time of stent removal. Conclusions: Malposition of JJ ureteric stent is uncommon, and omitting intraoperative position verification appears reasonable in select cases. If confirmation is required, cystoscopy detects 100% of malpositioned JJ stents. Alternatively, artificial bladder filling can help in detecting malpositioned JJ stents without repositioning the patient for cystoscopy. Introduction & Objectives: Urethral stricture disease is the narrowing of the urethra due to fibrosis. It poses a significant impact on the economy. Urethral strictures cause obstructive symptoms ad can be caused by a variety of aetiologies. The management of urethral strictures is a challenge. The treatment options available have high failure rates and many post operative complications. Our objectives were to determine the success and complication rates of BMG urethroplasties at Rockingham General Hospital. Methods: 17 patients who underwent single stage, ventral onlay BMG urethroplasty performed by one surgeon between 2013 and 2016 at Rockingham General Hospital (RGH), Western Australia were prospectively analysed. 13 patients had primary BMG urethroplasties, while 4 had redo BMG urethroplasties. All patients had previous failed dilatations. These patients had follow-up flexible cystoscopies at 3 months and 12 months post-surgery. Analysis included age, length of stricture, procedure time, post-op admission duration, complication and recurrence rates over the follow-up period of 12 months. Results: Mean age was 52 years. Mean stricture length was 2.62 cm. Mean procedure time was 136.7 min. 100% of the patients attended the 3-month follow-up while only 52.9% attended the 12-month follow-up. Success rates were 88.2% being recurrence free at 3-month follow-up cystoscopy while 88.9% were recurrence free at the 12-month period. Stricture recurrence was noted in 11.8% of patients at the 3-month follow-up while 11.1% were noted to have stricture recurrence at the 12-month follow-up. 24% had early complications (within 3 months) while none had ongoing complication at the 12-month follow-up. Conclusions: BMG urethroplasty is a safe procedure with good outcomes. Our success rates of 88.9% are comparable to success rates achieved in other studies. Minor early complications were noted in 24% of the patients while none had ongoing issues with complications 1 year post-op.
Uro-Oncology/ Robotics
Impact of body mass index on robotic radical cystectomy with intra-corporeal urinary diversion N. AHMADI USC Institute of Urology, Los Angeles, USA Introduction & Objectives: Major surgery in the obese is associated with inferior oncological outcomes and greater perioperative risks, such as higher operative time, blood loss and complications. We determined the impact of body mass index (BMI) on peri-operative and oncological outcomes in patients undergoing robotic radical cystectomy (RRC) with intra-corporeal urinary diversion. (obese class I), ≥35 kg/m 2 (obese class II). Pre-, intra-and post-operative parameters, oncologic outcomes, and 90-day complications were compared using SAS statistical software. Log-rank tests were performed for recurrence free survival (RFS) and overall survival (OS). Results: Of the 216 patients, 68 (32%) underwent orthotopic neobladder and all patients underwent intra-corporeal diversion. Demographics were similar between all four BMI groups with regards to median age (71.8; 35-95) ; gender (80.6% male); CCI (66.2% 0-1); pathological stage [Cis-T2: 119 (55.1%), T3-T4/N0: 40 (18.5%), Tx/N+: 57 (26.4%)]; median node count: 41 (IQR: 28, 53); and positive soft tissue margin rate: 9 (4.2%). There were no significant differences in length of stay, readmission, or 90-day overall and highgrade complication rates (p = 0.16, p = 0.89, p = 0.22, p = 0.51 respectively). Obese patients had higher blood loss p = 0.02 but there were no significant differences in the operative time of patients undergoing ileal conduit (p = 0.25) or orthotopic neobladder diversion (p = 0.11). At median follow-up of 13 months (Range 15 days-4.8 years), recurrence-free survival (p = 0.92) and overall survival (p = 0.68) were similar between the BMI groups.
Conclusions: RRC is safe and feasible in obese patients with bladder cancer. Body mass index was not associated with significant differences in perioperative, pathological, or early oncological outcomes.
Robotic radical cystectomy with intra-corporeal urinary diversion in elderly N. AHMADI USC Institute of Urology, Los Angeles, USA Introduction & Objectives: Major surgery in the elderly is associated with inferior oncological outcomes and greater perioperative risks, especially complications. We determined the impact of age on perioperative and oncological outcomes in patients undergoing robotic radical cystectomy (RRC) with intra-corporeal urinary diversion. Methods: A total of 216 patients who underwent RRC with extended lymphadenectomy (07/2010-12/2015) were categorized into four age groups: <65, 65-69.9, 70-74.9, ≥75. Pre-, intra-and postoperative parameters, oncologic outcomes, and 90-day complications were compared using SAS statistical software. Log-rank tests were performed for recurrence free survival (RFS) and overall survival (OS). Results: Of the 216 patients, all underwent extended pelvic lymph node dissection and intra-corporeal diversion. 68 (32%) patients underwent orthotopic neobladder for urinary diversion. Higher age groups had higher ASA (P < 0.01), Charlson Comorbidity Index (P < 0.01) and lower BMI (P = 0.05). There were no significant differences in pathological stage, lymphovascular invasion and positive soft tissue positive margin. Older groups had lower lymph node count (p < 0.01), were less likely to receive neoadjuvant chemotherapy (p = 0.01) or have orthotopic neobladder for urinary diversion (p < 0.01). Elderly had shorter operative time (P < 0.1) but longer length of stay (p = 0.04). There were no differences in operative blood loss, transfusion rate, readmission or complication rates (high or low grade). At median follow-up of 13 months (Range 15 days-4.8 years), recurrence-free survival (p = 0.46) and overall survival (p = 0.08) were similar between the age groups. Conclusions: RRC with intracorporeal diversion is safe and feasible in the elderly. Postoperative readmission and 90-day complication rates remain similar. Despite lower rates of neoadjuvant chemotherapy and lymph node count, the oncological outcomes remain similar in the elderly. Introduction & Objectives: The prognostic value of concomitant carcinoma in situ (CIS) in radical cystectomy (RC) cohorts for both muscle invasive bladder cancer (MIBC) and nonÀMIBC has been extensively studied. However its oncological impact remains poorly determined in the neoadjuvant chemotherapy (NAChT) era. Herein we examine the survival outcomes of RC patients post NAChT who had concomitant CIS in their final pathology. Methods: We reviewed our prospectively collected database, identifying 182 patients who underwent RC following NAChT from 1985 À 2011. Final pathology was reviewed for presence of concomitant CIS. Multivariate analysis, log rank tests and KaplanÀMe-ier curves were generated using statistical software SAS. Recurrence free survival (RFS) and overall survival (OS) were compared in MIBC and nonÀMIBC groups based on presence or absence of CIS. Results: Of the 182 patients, 105 (57.7%) had concomitant CIS on final pathology. Median age was 65 (IQR: 57,73) years and the median follow up was 9.3 years. The pathological staging distribution showed, 87 (47.8%) T0À2N0, 50 (27.5%) T3À4N0, 50 (24.7%) TxN+. The NAChT regimen included: 56(31%) MVAC, 63(35%) Gemcitabine/Cisplatin, and 63(35%) had other forms of chemotherapy. There were no significant differences based on sex, race, comorbidities or stage. Higher tumor grade (p < 0.001), lymphovascular invasion (p = 0.047) and multifocality of tumors (p < 0.001) were associated with significantly higher rates of concomitant CIS. Presence of CIS had no significant effect on RFS or OS in MIBC (p = 0.73, p = 0.45) or nonÀMIBC (p = 0.32, 0.45) using LogÀRank tests. Conclusions: Higher grade, lymphovascular invasion and multifocality of primary tumor are associated with higher risk of concomitant CIS at radical cystectomy after neoadjuvant chemotherapy; however it does not influence oncologic outcomes.
Management of high risk nonmuscle invasive bladder cancer: is re-resection always essential?
Introduction & Objectives: Several international guidelines recommend repeat transurethral resection of bladder tumour (TURBT) for patients diagnosed with high risk non-muscle invasive bladder cancer (Ta and T1 high grade tumours). These recommendations are based on the risk of under staging bladder tumour (BT) on the initial TURBT. However despite re-resection offering a potential for more accurate staging of disease, repeat procedures do expose patients to risk of peri-operative morbidity and complications as well as place additional costs on the health care system. Since its inception in 2008 at Fremantle hospital and its subsequent transition to Fiona Stanley hospital in 2015, there have been over 2000 patients reviewed in the one stop haematuria clinic (OSHC). We retrospectively reviewed patients diagnosed with high risk NMIBC in the OSHC between 2009 to June 2015. Our primary aim was to review the histopathology results from re-resection of patients who were initially diagnosed with high risk NMIBC to evaluate for early recurrence or residual disease. The secondary aim was to compare the post induction and maintenance Bacillus Calmette-Gu erin (BCG) therapy outcomes for patients who underwent re-resection to those who did not undergo re-resection. Methods: A retrospective review of all patients diagnosed with high risk NMIBC in the OSHC was performed between Jan 2009 to June 2015 using prospectively collected data from the OSHC data base. Patients' case records were interrogated to identify their demographic details, the stage and grade of tumour on the initial TURBT and whether re resection was performed. For those patients that proceeded to having a course of BCG therapy their histopathology results from post induction and maintenance BCG treatment were also recorded.
Where possible reasons for not performing re-resection were recorded. Patient who did not complete course of maintenance BCG were excluded from comparative analysis. Results: A total of 178 patients were diagnosed with Bladder cancer of which 57 patients, 50 (87.7%) male and 7 (13.3%) female, had high risk NMIBC between the periods of 2009 to 2015. 21 patients had Ta high grade bladder cancer of which 10 (47.6%) patients underwent re-resection with no upstaging of disease found. 2 out of these 10 patients however did have residual/recurrent bladder tumour. 36 patients had T1 high grade bladder tumour of which 25 (69.4%) patients underwent re-resection with no upstaging of disease. 12 out of the 25 patients did however have residual/recurrent disease at the time of their re-resection. 33 out of the 36 patients with T1 high grade disease proceeded to BCG therapy. 1 patient had Ta high grade disease post completion of BCG therapy. All high risk NMIBC patients that did not undergo reresection and completed BCG treatment did not have any evidence of recurrence on their bladder biopsy following completion of BCG therapy. Conclusions: In our series, patients who underwent re-resection TURBT for high grade NMIBC did not have any upstaging of disease. There was no difference in rates of recurrence of BT in patients who underwent re-resection when compared to those who did not undergo re-resection following a complete course of BCG therapy.
Cribriform pattern prostate cancer predicts for PSMA visible nodal metastatic disease Introduction & Objectives: GA68 PSMA PET is a novel technology utilized in the imaging of prostate cancer. This study is of particular interest in regard to its ability to potentially image nodal and distant metastatic disease in the setting of biochemical failure after radical prostatectomy. It is well recognized however that not all patients with detectable PSA readings after radical prostatectomy will have lesions visible on GA68 PSMA PET. We sought to identify the histologic features common to those metastatic deposits visible on PSMA PET scanning. Methods: We conducted a review of a prospectively collected database of the cases of three urologists who had undertaken cases of extended pelvic lymph node dissection in order to excise GA68 PSMA PET avid lesions noted on scanning In each instance imaging had been performed in order to potentially identify metastatic deposits in the setting of a rising PSA level after earlier radical prostatectomy. 10 patients were identified (mean age 62 years range 55-76 years). Histologic specimens taken at surgery were reviewed by a single uropathologist. Results: Metastatic adenocarcinoma was identified in 9 of 10 specimens taken at extended pelvic lymph node dissection, where the surgical template was based upon the results of the GA68 PSMA PET scan. In all 9 of these10 patients with metastatic disease there was evidence of metastatic cribriform growth type prostatic adenocarcinoma, often associated with ductal adenocarcinoma (noted in 7 of 9 patients with metastatic disease).
Conclusions:
Although not all patients with biochemical failure after radical prostatectomy will have lesions visible on GA68 PSMA PET scans, when this study does show evidence of pelvic lymph nodal disease this is likely to correlate with the presence of metastatic cribriform growth type prostatic adenocarcinoma and often also with ductal adenocarcinoma of the prostate in these areas. Consideration should be given to treatment by surgical, radiation or androgen deprivation therapies in this instance. Introduction & Objectives: The re-introduction of multiparametric MRI (mpMRI) into the care process of men with prostate cancer has led to the need for the definition of its utility and limitations in clinical practice. The variation in uptake of this modality between clinicians has created various patient cohorts. We present a consecutive series of patients who underwent mpMRI of the prostate prior to trans-perineal biopsy. Methods: Consecutive patients reviewed in the outpatient setting were reviewed with MRI prior to prostate biopsy. All biopsies were by the transperineal approach. All procedures involved grid directed biopsies according to Victorian Transperineal Biopsy Collaboration template. Patients who were reported to have an index lesion on mpMRI also underwent MRI fusion targeted biopsies of the abnormality. Histopathology was reviewed and analyzed for longest core length involving cancer, highest Gleason grade cancer location and in cases of targeted biopsy, whether this site matched either of these two criteria. Biopsy results were also analyzed for average number of cores and for correlation between PIRADS grade and cancer presence. Results: 44 consecutive patients met inclusion criteria.21 patients had an index lesion on mpMRI that were targeted on biopsy. Of these, less than 50% of patients displayed the target site as the largest core of prostate cancer, but more than 75% of target lesions biopsied were revealed as the location for the highest Gleason grade pathology. 2 patients that underwent targeted biopsy did not reveal cancer in any sites. Of the patients that underwent standard template biopsies, prostate cancer (Gleason 6) was revealed in 50% of patients with only one patient displaying higher-grade carcinoma (Gleason 4 + 3). Average numbers of cores taken were 25 and 24 for template and targeted biopsies respectively. Conclusions: mpMRI has displayed its value in the identification of suspicious lesions of the prostate and can help to guide biopsy to increase diagnostic yield, however, mpMRI is not sufficient to rule out all areas of clinically significant prostate cancer. Targeted biopsies of MRI index lesions alone would fail to reveal prostate cancer in other areas of the prostate and would not have been sufficient for adequate clinical decision-making in our cohort. Introduction & Objectives: Surgical audit and peer review are an important requirement for maintaining clinical standards. An audit allows for a critical review of a surgeon's performance and helps maintain professional standards. The audit cycle is completed with the results are reviewed and feedback is offered to redress any identified problems. An audit of open radical prostatectomy surgery was chosen as it was a relatively complex surgery being performed by half the consultants within the department. Methods: We prospectively collected data from radical prostatectomies performed by four consultants in a large teaching hospital between January 2010 and February 2015. The results were presented at an audit meeting after three years. Techniques were discussed and peer teaching undertaken including observing other surgeons operating. The audit has continued for a further three years.The outcome measures presented in this paper are length of operation, blood loss and pad usage at one year. Results were analysed using the Fisher's exact test. Results: 428 men underwent radical prostatectomy at Christchurch Public Hospital during this time. Age ranged from 41-76 year with a median of 65 years. 351(82%) completed the pad usage surveys at one year.
The trainee performed some or all of the surgery in 27% of the patients and 73% (257 patients) were performed completely by the consultants. Median operating time was 105 minutes (range 42-184 mins).
Median blood loss was 500mls (range 100-3000mls). During the first three years of data collection 128 men had surgery and 62.5% wore no pads at one year. After audit review 129 men underwent surgery and 71% wore no pads at one year (p = 0.1461). When looking at individual surgeons there was a large variability in continence rate with one consultant's results showing only 35% wearing no pads and 12% needing 3 or more pads. However after review these figures improved to 64% and 0% respectively. Conclusions: This study has shown the value of a peer reviewed audit within a urology department. Though the results did not show a statistical significance there was a clinical benefit in outcome to the patients. Conclusions: Our study suggests antibiotic prophylaxis using single dose Ciprofloxacin is associated with higher readmission with infection. This study favours the consideration of a revised antibiotic protocol.
Outcomes of radical cystectomy at a regional centre in NSW: a 14 year review
Introduction & Objectives: Radical cystectomy with urinary diversion is the definitive surgical treatment for muscleinvasive and high-risk non-muscle-invasive bladder cancer that is refractory to BCG. It carries significant short-term perioperative risks of morbidity and mortality, however, provides these patients with the best chance of cure from their disease. In this study, we review the short term perioperative outcomes and the pathological and oncological outcomes of radical cystectomy performed at a regional centre. Introduction & Objectives: Transperineal biopsy continues to gain acceptance as a preferred approach to prostate biopsy. As more multiparametric MRI is performed pre-biopsy, MRI-ultrasound (US) fusion platforms are being explored in the transperineal setting. This study aimed to assess the initial Australian experience using a novel robotic device -the iSR'obot Mona Lisa -to perform MRI-US fusion transperineal biopsy. Methods: Institutional ethics committee approval was obtained for a prospective database. Data entered included PSA, biopsy indication, clinical stage, Prostate Imaging -Reporting And Data System (PI-RADS) score, targeted and template core number, biopsy grade group, and biopsy complications. Clinically significant cancer was defined as Grade Group (GG) 2 or higher. All patients underwent biopsy under general anaesthesia. Single dose intravenous cephazolin only was used as antibiotic prophylaxis. Where prior MRI was positive, the prostate and tumour were modeled on transverse T2-weighted slices using the Mona Lisa software. The rectal US probe was inserted and an US model of the prostate was created using 0.5 mm slices in the transverse plane. The MRI and US images were fused and both targeted and template cores were taken via only 2 skin punctures in a biconical configuration. Results: From July 2015 to September 2016, 58 men underwent prostate biopsy using the iSR'obot Mona Lisa. Mean PSA was 9.4. DRE felt benign in 40 (69%). 47 (81%) were biopsy-na€ ıve. 49 (84%) had a prior MRI. Of the 47 MRIs that had a PI-RADS score assigned, 8 (17%) were PI-RADS 2, 5 (11%) were PI-RADS 3, 16 (34%) were PI-RADS 4 and 18 (38%) were PI-RADS 5. Mean number of targeted cores was 6.4. Mean number of template cores was 23.8. None of the 8 patients with a negative MRI (PI-RADS 2) had significant cancer. Of 5 PI-RADS 3 cases, targeted and template cores detected 2 versus 1 GG2 cancers, respectively. Of 16 PI-RADS 4 cases, targeted and template cores detected 7 versus 9 GG2 and 2 versus 1 GG3 cancers, respectively. Of 18 PI-RADS 5 cases, targeted and template cores detected 7 versus 7 GG2 cancers, 3 versus 2 GG3 cancers, 2 versus 4 GG4 cancers, and 4 versus 3 GG5 cancers, respectively. Targeted cores missed GG2 in 3 patients and undergraded 3 significant cancers. Template cores missed GG2 in 4 patients that were detected on targeted cores only, and undergraded 5 significant cancers compared to targeted cores. 3 (5%) patients developed urinary retention. No patients suffered infection. Conclusions: The iSR'obot performs robotic MRI-ultrasound fusion transperineal prostate biopsy via two skin punctures safely and with high accuracy. Overall, targeted cores detected at least as many significant cancers as template cores. In line with other series, taking both targeted and template cores is recommended for optimal cancer detection and grading. and median total tumour volume were assessed. The results were then broken down into tranches of 100 each spanning 1-2 years in order to evaluate changes in these parameters over that time frame. Results: A significant shift was noted in the clinical D'Amico risk from low to intermediate which was progressive over the 11 years. There was a shift in the pathological stage from comprising 2/3 pT2 and 1/3 pT3 to comprising 1/3 pT2 and 2/3 pT3 in the last tranche. This was most noted in the last 3 tranches beginning in 2011. There was a change in the ratios of the Grade Groups, with a reduction in Gleason 6 cancers mirrored by a corresponding increase in Gleason 8 and 9 disease. There was no real change in the number or ratios of Grade Groups 2 and 3. There was an increase in age and a significant increase in total tumour volume apparent mainly in the last 2 tranches of 200 cases. There was however no apparent change in the median PSA level over the entire 11 years. • Survey response rate -50%
• Acceptance rate for telephonic notification -100%
• Satisfaction with the OSPC -96%
Conclusions: Overall satisfaction levels with the OSPC were extremely high and only 2 men (both with cancer) with hindsight would choose not to receive notification of biopsy results via a phone call. Perceived advantages of prompt notification of diagnosis and awareness of follow up arrangements were highly rated. TURBT (median 56, . The median duration of NAC was 84 days (32-119). Of patients not receiving NAC, a higher proportion (85.7%) underwent cystectomy within 12 weeks (median 48 days; 14-112). The median interval between NAC and cystectomy was 39 days (21-122). Of the 12 (28.6%) patients where cystectomy was delayed more than 12 weeks, 9 were from external referral base, 2 referred to perioperative assessment, 3 had TURBT within 18 days of a public holiday. 28 (66.7%) patients who had MDT discussions preoperatively had a median time from TURBT to cystectomy of 65 days (14-261), with time from MDT to cystectomy at 25 days (3-360). Pathological staging was as follows, T0 -4 patients, Ta -1, Tis -1, T1 -3, T2 -6, T3 -14 T4 -11, N1 -7, N2 -5, N3 -1. All urothelial except for T3-1 SCC, 2 mixed SCC/ urothelial., T4 -1 SCC, 1 -mixed SCC/ urothelial) Overall Clavien Gr1-2 complication rate was 30% (14), Gr3-5 was 9% (4). Overall mortality was 40% (17). 30-day perioperative mortality 2% (1) and cancer specific mortality was 36% (11). At present, 5-year survival rate was 36% (11). Median LOS was 14 days (7-32).
Conclusions: This descriptive analysis revealed comparable results to previous studies in low-volume centers for timing, mortality, complications, survival. NAC delays surgery more than previously published, but our interval from NAC to cystectomy was similar. Whilst there is evidence based survival benefits of NAC, considerable delays in NAC pathway may dilute or remove that survival benefit. Introduction & Objectives: With the introduction of 68-Gallium labelled prostate specific membrane antigen (PSMA) binding ligand and positron emission tomography (PET), it has become possible to visualize small lesions in the early phases of biochemical recurrence after primary treatment of prostate cancer. In this case series from two separate tertiary institutions, we prospectively collected patient information to determine the distribution of cancer recurrence after primary surgery both before and after salvage radiotherapy. Methods: Prospectively collected database was established between Queensland XRay (QXR) and Princess Alexandra Hospital (PAH), Queensland. Patients had the PSMA PET study performed at one of two QXR sites or at PAH using the same imaging protocol. All patients attending for the PSMA PET were eligible for the study. This is an interim analysis of the first (4) months of data collection of patients presenting for staging with newly diagnosed prostate cancer. Where available final histology from prostatectomy specimens was correlated with the PSMA uptake within the prostate. Results: The study consisted of 112 patients undergoing PSMA PET for biochemical recurrence after primary treatment of localized prostate cancer. 72 patients underwent radiotherapy (39 primary and 33 salvage radiotherapy). 40 patients had surgery as their primary treatment.
In patients who underwent primary surgery, 13 (of 40) were found to have lymph node disease (32.5%), 10 of which were found within the pelvis and 2 with local recurrence. 9 patients were found to have non-lymphatic metastatic disease (22.5%) with six of these patients having bony metastatic involvement. Median PSA for PSMA PET in this group was 0.88 (ng/ml).
Of the 32 patients who underwent salvage radiotherapy and had progressive PSA, the average PSA was 4.0 (ng/ml). 17 patients were found to have lymph node disease within the pelvis (53%). 8 patients had bony metastatic disease (25%) and 6 had non-bony, metastatic lesions (19%). Local recurrence was found in one patient after salvage radiotherapy.
Of the 112 patients involved in the study detection rate for any tumour foci was 20% for patients with a PSA between 0 -0.5 (ng/ml). The detection rate was 80% for patients with a PSA > 1 (ng/ml). Conclusions: In conclusion, this study demonstrates that PSMA PET is able to detect metastatic disease in different treatment settings. This includes the detection of metastatic lesions even in patients with a low PSA of 0 -0.5 (ng/ml). Introduction & Objectives: The removal of renal mass by robot assisted partial nephrectomy (RAPN) is inevitably followed by a decrease in renal function. Theoretically, in the presence of normalfunctioning contralateral kidney a surmountable time to nadir should not be observed. We investigated the impact of postoperative time to nadir estimated glomerular function rate (eGFR) on renal functional changes after RAPN. Methods: From 2006 to 2015, 287 patients with renal mass who underwent RAPN were analysed. The cohort was evaluated based on their time to develop nadir eGFR: group 1 (no nadir), group 2 (<48 hours) and group 3 (≥48 hours). Primary outcome was to evaluate the renal function recovery between groups. Secondary outcome was to evaluate risk factors for development of nadir ≥48 hours using logistic regression analysis. Results: Cumulative eGFR percentage change was worst in group 3 compared to groups 1 and 2 with 13.8%, À0.67% and 8%, respectively. (p < 0.001) CKD upstaging was more common in group 3 compared to other groups (p < 0.001). Age, tumour size, PADUA score and blood loss were predictors of developing ≥48 hours nadir eGFR (HR: 1.03, p = 0.001; HR: 1.24, p = 0.001; HR 1.25, p = 0.002; HR: 1.01, p = 0.034), respectively. Retrospective design was the main limitation of this study. Conclusions: A continuous decline in eGFR (≥ 48 hours) after RAPN is associated with increased risk of poor functional recovery over time. Age, increased tumour size, high PADUA score, and blood loss were independent predictors of developing nadir eGFR ≥48 hours post operatively. Although further studies would be needed to verify our findings, these patients may require closer monitoring due to its potential significance on CKD upstaging. Introduction & Objectives: Partial nephrectomy has been the mainstay of surgical treatment for T1 renal mass due to its significant renal functional benefit compared to radical nephrectomy. However, a paucity of information is available with regards to long term renal function following Robot assisted partial nephrectomy (RAPN). Moreover, there is a wide variation of renal function postoperatively. We sought to investigate long term renal function and to identify predictors of recovery to preoperative renal function following RAPN. Methods: A retrospective review of prospectively collected data of RAPN was analysed. Patients with a minimum of 5 year follow up were included. Patient clinicopathologic characteristics as well as perioperative outcomes were assessed. eGFR was measured preoperatively, daily from time of surgery till discharge, 1 month, 3 month, 6 month, 1 year, then annually thereafter. Patients who achieved full recovery of renal function to preoperative eGFR (Group 1) were compared with ones who did not (Group 2). Multivariable regression analysis was performed to identify predictors of return to baseline renal function. Results: Of 152 patients, 61 (40%) achieved return of their renal function to baseline eGFR. Mean preoperative eGFR was 85.8 and 94.3 ml/min/1.73 m 2 in the group 1 and group 2, respectively (p = 0.004). The change in eGFR was consistently less in group 1 from early postoperative period up to 5 years. Renal function continued to improve beyond two years post operatively in a significant number of patients. Lower preoperative eGFR, age < 65 years, and patients with no history of hypertension and diabetes were predictors of full recovery of renal function on multivariate analysis. Conclusions: Lower preoperative eGFR, absence of hypertension and diabetes and age < 65 years were predictors of recovery to preoperative renal function following RAPN. These parameters could be considered to be potentially valuable during preoperative counseling of patients undergoing RAPN.
Ethnic patterns of prostate cancer in the southwest region of Trinidad and Tobago, West Indiescomparison between Africans and East Indians Introduction & Objectives: There are 2 major ethnic groups in Trinidad and Tobago -Africans and East Indians with ancestry from mainland Africa and India respectively. The aim of this study was to compare the patterns of prostate cancer between these two major ethnic groups. Method: The study population consisted of all patients presenting to the San Fernando General Hospital for treatment of prostate cancer between the periods 2002 to 2007. Clinical data from patient records were analyzed using prostate cancer related variables: age, ethnic background, family history of prostate cancer, DRE findings, serum PSA values at presentation, Gleason's scores, imaging results and treatment mode. Comparative analyses of two ethnic groups -African Trinidadians and East Indian Trinidadians were undertaken.
Results: A total of 546 men underwent treatment for prostate cancer at the San Fernando General Hospital in Trinidad. 387 (71%) had surgical treatment (radical retropubic prostatectomy, brachytherapy or bilateral orchidectomy) and 159 (29%) had non-surgical treatment (hormonal therapy). The mean age of the study population was 71.07 yrs. 63% of patients were African-Trinidadians, 21% East IndianTrinidadians and 16% were of other races. The prevalence rate of prostate cancer in Africans was found to be 205 per 100,000 and East Indians 32 per 100,000. However risk stratification into low vs intermediate vs high-risk groups using PSA values and Gleason's scores (D'Amico risk classification) showed no significant differences between the two ethnic groups. 63% Africans vs 62% East Indians were categorized in the high risk group (Pearson Chi 2 test = 3.21; p = 0.523); 15% Africans vs 11% East Indians in the low risk group and 22% Africans vs 27% East Indians in the intermediate group.
Conclusions: Prostate cancer in Trinidad is more prevalent among men of African ancestry as opposed to those of East Indian origin. However, there is no significant difference in the age or risk category at presentation between the ethnic groups.
Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation Introduction & Objectives: Benign uretero-ileal anastomotic stricture is a significant complication following radical cystectomy and ileal conduit urinary diversion after radical cystectomy. The aim of this study was to review our experience with radical cystectomy and ileal conduit diversion to interrogate risk factors for uretero-ileal anastomotic stricture. We examined these risk factors for stricture formation to predict those at greatest stricture risk. Methods: A retrospective chart review was conducted for patients undergoing radical cystectomy and ileal conduit diversion between 2002 and 2012 at 3 hospitals (1 public, and 2 private) in Melbourne, Australia. Patient records were reviewed to capture demographic data including gender, age, body mass index, medical comorbidities, prior chemotherapy, and smoking history. Preoperative data was also collected, including hemoglobin level, serum urea and creatinine, and albumin level. Intraoperative and post-operative data recorded included length of surgery, use of inotropes, requirement of blood transfusion, sepsis, and evidence of anastomotic urine leak. Demographic data and patient variables were analyzed to determine risk factors for uretero-ileal stricture using multivariate logistic regression. Results: Over the study period, 133 patients underwent cystectomy and ileal conduit formation, with 14 (10.5%) developing uretero-ileal anastomotic stricture. Of 133 patients, median age was 70, with 98 (73.7%) males. 30 (22.6%) patients were diabetic, and mean serum urea level was 6.2 (range 1.3-15). Diabetes and elevated serum urea level (defined as > 7.1 mmol/ L) were associated with increased risk for development of uretero-ileal stricture (Odds ratio 4.31 and 4.28 respectively, p < 0.05 for each). There was a strong trend towards an increasing proportion of strictures as the number of risk factors a patient had increased (p < 0.001). Having at least one of these risk factors was strongly predictive of subsequent stricture development (OR=17.3, p = 0.007) with associated sensitivity of 92.9% and specificity of 57.1%. Conclusions: In this patient cohort, diabetes and elevated serum urea level were predictive for the development of ureteroileal anastomotic stricture. We hope this may assist in assigning a relative risk for future development of uretero-ileal anastomotic stricture, allowing targeted trial of specific preventive strategies. Further prospective study with larger patient samples is required. Introduction & Objectives: Post-operative urinary incontinence is a significant concern for patients choosing to undergo a radical prostatectomy for treatment of prostate cancer. Surgery is offered to older patients with caution due to concerns about poor continence. Whilst it has been established that older patients have worse continence outcomes after open radical prostatectomy, there has been promising data suggesting that RALP is not associated with poorer continence in older men. Furthermore, a recent systematic review and meta-analysis of studies reporting urinary continence outcomes post RALP has suggested that factors such as a large body mass index (BMI) and large prostate volumes were significant pre-operative predictors of continence outcomes.The aim of our study was to determine the effect of age, BMI and prostate volume at time of surgery on 12 month continence outcomes in men having RALP. Methods: Using the South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC) database, we identified patients who had undergone RALP by a high volume surgeon (>50 cases per annum) between March 2012 and March 2015. Accurate prostate measurements were taken from the patients' pre-operative magnetic resonance imaging (MRI) reports. The 26-item short-form version of the Expanded Prostate Cancer Index Composite (EPIC) was used to measure continence outcomes. All patients who received an assessment and education by a specialist pelvic floor physiotherapist and had completed EPIC questionnaires before and after treatment were included in this study. Exclusion criteria included salvage radiotherapy and BMI >50. Continence outcomes compared with age was evaluated in 449 patients (age range 45-76 years old); continence rates associated with BMI was analysed in 357 patients and the association between continence outcomes and prostate volume was analysed in 334 patients. Results: Baseline continence declined with increasing age (b À0.23, p < 0.01). On average, patients had poorer continence 12 months post RALP when compared with pre-treatment levels; however age was not associated with this decline (p = 0.98). This observation did not change with adjustment for potential confounders including surgical margin status, nerve sparing technique, pathological stage or pre-treatment continence scores (p = 0.41). Logistic regression of 357 patients showed no change in pre-operative urinary continence with increasing BMI. There was also no identifiable association between BMI and urinary continence post RALP in mixed effects linear modelling. There did not appear to be a significant correlation between prostate volume and baseline continence levels (logistic regression, p = 0.18). However, larger prostate size was a significant factor affecting post RALP continence outcomes (p = 0.02), even after adjustment for baseline continence (p = 0.01). Conclusions: This is one of the largest Australian studies investigating continence outcomes in patients undergoing roboticassisted laparoscopic radical prostatectomy and the association with common predictive factors such as age, BMI and prostate volume. While prostate volume was found to be a significant predictor of post-operative continence, neither age at time of surgery nor preoperative body mass index were associated with a change in continence outcomes 12 months following RALP by high volume surgeons in patients who underwent a specialist pelvic floor physiotherapy assessment and education program.
Preoperative neutrophil-lymphocyte ratio predicts more aggressive pathology and poorer survival among patients with localised renal cell carcinoma undergoing nephrectomy R. MANGAT, K. CHEN and W. LAU Singapore General Hospital, Singapore, Singapore
Introduction & Objectives: The neutrophil to lymphocyte ratio (NLR) is a widely available, easily reproducible and affordable indicator of systemic inflammatory response. The NLR correlates with cancer related inflammation and has been associated with adverse oncological outcomes in multiple malignancies including gastric, lung and colorectal. We hypothesize that a higher preoperative NLR ratio is associated with adverse outcomes in patients with localized renal cell carcinoma (RCC) treated with radical nephrectomy (RN). We aim to evaluate pre-operative NLR with clinical, pathological and oncological outcomes and examine its prognostic value. Methods: Data of all patients who underwent radical nephrectomy for localized RCC between 1979 and 2014 were analysed retrospectively. NLR was calculated from pre-operative bloods taken within a month prior to nephrectomy. Multivariate analysis using cox regression model were used to investigate an association of NLR and clinicopathological outcomes. NLR was analyzed as a continuous and categorical variable (cut-off of 1.7 and 4), using comparison of median as well as Pearson Chi square respectively. Metastasis-free and overall survival was measured from time of RN using Kaplan-Meier analysis. Multivariate COX proportion analysis was performed to determine. Results: The median age of the 677 patients included was 58.5 years (29.5-91.1). 439 (65%) were male and 239 (35%) were female. At follow-up, 119, 60, and 117 patients had distant metastasis, death from RCC, and all-cause mortality respectively. Cox proportional analysis of NLR as a dichotomous variable confirmed a cut-off point of 1.7 as the strongest prognostic value in our dataset. Using this cutoff for further analysis, patients with NLR > 1.7 were more likely to have aggressive tumour biology. Pathologically, there was a strong correlation between NLR > 1.7 and coagulative tumor necrosis, sarcomatoid differentiation and higher stage tumors (all, p < 0.05). An elevated NLR was significantly associated with Fuhrman grade when analyzed as a continuous and categorical variable (p < 0.001 and p < 0.046 respectively). Kaplan Meier and Log Rank analysis showed that a NLR> 1.7 was a significant prognosticator for poorer overall survival (p = 0.002) and cancer specific survival (p = 0.029). NLR > 1.7 was associated with poorer overall survival when corrected for SSIGN (p = 0.013).
Conclusions: NLR appears to have prognostic value in patients with localized RCC undergoing RN and predicts for more aggressive tumor biology as well as poorer survival. NLR may add value to pre-operative prognostication and risk stratification of patients with localized RCC.
Metastatic ureteric lesions from the prostate: a review of contemporary literature Introduction & Objectives: True metastatic ureteric lesions are exceptionally rare when sourced from any primary tumour. Primary prostatic cancer metastasis to the ureter is understandably even more atypical with less than 50 cases reported in current literature. True intramural ureteric metastatic disease deposited from prostate cancer is an even rarer occurrence. We detail current hypotheses regarding the subsequent pathophysiology of the disease and its common clinical presentations in addition to presenting an example of one such case. Methods: A formal PRISMA review of contemporary literature was undertaken utilizing EMBASE, Web of Science and PubMed regarding metastatic deposits to ureter and rare pathways of metastatic prostate cancer. Additionally, data was collated pertaining to a recent case consistent with this diagnosis at our institution, to highlight these reportedly common clinical manifestations and provide a strong example of the typical intraoperative and histopathological findings. Results: Although uncommon, metastatic deposits to the ureter have previously been reported from primary breast, stomach and bladder neoplasms and atypical sources such as cervix and colon. Particularly, non-urinary tract metastatic ureteric malignancies are extraordinarily rare. Apart from a single review article, medically based evidence regarding metastatic deposits in ureter from a prostatic primary source are limited to case reports.
Our brief case includes many of the salient features described in contemporary literature concerning ureter metastatic lesions from prostate cancer, including intramural obstruction resulting in hydronephrosis and loin pain. As well as the existence of high grade prostate cancer. Conclusions: Given the underlying rarity of truly metastatic ureteric lesions from any primary source, lesions from a prostatic primary represent an increasingly atypical series. Our case adds to the limited existing literature of approximately 50 previously reported cases. Despite how uncommon these lesions are, urologists must always consider the possibility of a metastatic etiology in ureteric mass, including from primary prostate cancer. Conversely in high-grade prostate cancer with co-existing hydronephrosis clinicians should also carefully consider the possibility of a sinister metastatic mass causing obstruction. Investigation of the cause of hydronephrosis with cystoscopic evaluation of the ureteric orifices should be performed to rule out distal ureteric involvement by primary or secondary lesions.
68 Ga-PSMA PET/CT in two patient groups in a regional centre: patients with biochemical recurrence after definitive treatment, and primary staging of prostate cancer. Methods: Patients who underwent a PSMA scan between December 2015 and August 2016 who were treated on the Central Coast were evaluated. Sixty-one patients of seventy met this definition and were included in the retrospective analysis. All patients underwent a contrast enhanced PET/CT after injection of 68 Ga-PSMA ligand. Two groups of patients were evaluated: pre-treatment staging and biochemical recurrence after definitive treatment. Detection rates were correlated with pre-test PSA level and PSA doubling time.
Results:
68 Ga-PSMA PET imaging was performed for biochemical recurrence in thirty-four patients. Overall detection rate was 67.6% (n = 23). Mean time since definitive treatment was 6.6 years (range 0.2 to 22.9). Mean pre-test PSA was 5.31 ng/ml (range 0.1-28). Detection rates increased with both a higher PSA (100%, 57.1%, 40% and 0% for levels of >2, 0.5-2.0, 0.2-0.5, and <0.2) ng/mL respectively) and a shorter PSA doubling time (72.7%, 83.3% and 84.6% for >6, between 4-6 and <4 months respectively). Compared with contrast enhanced CT, 68 Ga-PSMA ligand PET provided exclusive pathologic findings in 32.4% (n = 11) of patients, and identified additional lesions in 26.5% (n = 9). Twenty-seven patients underwent 68 Ga-PSMA PET scanning for primary staging. Mean pre-test PSA was 14.5 ng/dL (range 3.62-57). Metastatic disease was identified in 22.2% (n = 6); four of those cases (66.7%) were identified exclusively by PSMA imaging.
Conclusions:
68 Ga-PSMA ligand PET/CT imaging shows a significant benefit over other staging scans by detecting a greater number of pathologic findings both in the primary staging of prostate cancer, and in the setting of biochemical recurrence, and thus has great potential in influencing management of these patients. To our knowledge these results are the first reported from a regional Australian centre, and concur with data from local and international metropolitan centres. Introduction & Objectives: Ureteric instrumentation to investigate suspected upper tract urothelial carcinoma (UTUC) poses a theoretical risk of tumour cells seeding from the upper urinary tract to the bladder, as well as into the lymphovascular space from irrigation during ureteropyeloscopy. Our objectives were to investigate whether there is a difference in 1) the incidence of, and 2) time to disease recurrence (lower urinary tract and metastatic) for patients undergoing diagnostic ureteric instrumentation prior to radical nephro-ureterectomy (RNU) for UTUC. Methods: A retrospective review of all patients who underwent RNU for UTUC at The Canberra Hospital (ACT, Australia) between January 1990-December 2014 was undertaken. Diagnostic ureteric instrumentation prior to RNU was defined as having undergone retrograde pyelography (RPG), selective ureteric washings, ureteric stent insertion or ureteroscopy (+/-biopsy). Patients who proceeded straight to RNU without ureteric instrumentation served as the control arm. Statistical analysis was performed with Kaplan-Meier methods to compare recurrence free rates and Cox Hazard models for multivariate analysis of risk factors for recurrence of UTUC. Results: 77 patients were included in this study of which 60 patients (77.9%) underwent some form of diagnostic ureteric instrumentation. In the ureteric instrumentation group a significantly higher proportion of patients, 44 (73.3%), developed recurrence compared to four patients (23.6%) in the non-instrumented group (HR=5.42; 95% CI 1.93-15.21; p = 0.001). Subgroup analysis found no statistically significant difference between the control group and intravesical recurrence (p = 0.57) or metastatic recurrence (p = 0.71) respectively. The median time to recurrence for the ureteric instrumentation group was much shorter, 8.2 months (IQR 4.0, 21.4 months), compared to the non-instrumented group where the median time to recurrence was 34.6 months (IQR 9.9,79.0 months; p = 0.02). In subgroup analysis there was no statistical significance in the median time to intravesical recurrence (p = 0.19) or metastatic recurrence (p = 0.47) in the instrumentation group versus the control group, Conclusions: The odds of disease recurrence was 5.4 times greater in patients undergoing diagnostic ureteric instrumentation prior to RNU for UTUC at any given point in time. The median time to recurrence was 4.2 times earlier compared to patients who proceed directly to definitive surgery. Future studies should investigate the individual effects of diagnostic retrograde pyelography, selective ureteric washings, ureteric stent insertion and ureteropyeloscopy (+/-biopsy) on UTUC recurrence.
Peri-operative blood transfusion in patients undergoing nephroureterectomy for upper tract urothelial carcinoma: an ACT experience A. MARE Calvary Hospital, Bruce, Australia Introduction & Objectives: It has been suggested that there is an increased risk of tumour recurrence in patients undergoing perioperative blood transfusion (PBT), We wanted to investigate the incidence and indications for peri-operative blood transfusion (PBT) in patients undergoing radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) and its effect on tumour recurrence. Methods: Retrospective review of all patients who underwent RNU for UTUC at The Canberra Hospital (ACT, Australia) over a 25-year period between 1990 to 2014. All patients who received a PBT and the indications for the transfusion were recorded against the control arm that did not receive a PBT. We analysed the incidence of disease recurrence between the two groups as well as adherence to the established Blood Transfusion Protocol at The Canberra Hospital. Results: 77 patients were included in our study with 23 patients (29.9%) receiving a PBT. Median blood loss in this group was 500 mls (range 100-1800 mls) with 2.2 units (range 1-4 units) being transfused on average, whilst the median blood loss in the non-transfused group was 475 mls (range 100-1300 mls) with no statistically significant difference found between the two groups (p = 0.29). Smokers were less likely to undergo a PBT (p = 0.07). In the PBT group, 39.1% of patients had a pretransfusion haemoglobin level > 100 g/L whilst only 8.7% of patients had a pretransfusion haemoglobin level of < 80 g/L. In 87% of patients the indication for the blood transfusion was unclear. Median length of stay was shorter in the non-PBT group (9.5 days) compared to the PBT group (14.0 days; p = 0.04, 95% CI 3.90-10.34). Patients who underwent laparoscopic RNU had a lower median blood loss (465 mls) compared to the open RNU group (648 mls; p = 0.02, 95% CI À338.9 to À24.9) and were also less likely to undergo a PBT (p < 0.001, 95% CI À0.67 to À0.32). 56.5% of patients in the transfused group had recurrence of disease, compared to 64.8% in the non-transfused group (p = 0.37). Median time to UTUC recurrence in the PBT-group was 13.6 months (IQR 3.4, 34.1) compared to the non-PBT group where it was 10.5 months (IQR 4.2, 31.5) however this was not a statistically significant difference (p = 0.53).
Conclusions: Blood transfusion rates for patients undergoing RNU for UTUC in this cohort were almost double the reported rate in other multi-institutional studies with poor adherence to the hospital blood transfusion protocol. In addition, there was no clear clinical indication documented for 87% of transfusions. The median length of stay was shorter in patients not undergoing a PBT and those patients that underwent laparoscopic RNU had lower rates of blood loss and a smaller risk of undergoing PBT compared to those patients that underwent an open RNU. The risk of UTUC recurrence was lower in the transfused group with a longer time to tumour recurrence, however these differences were not statistically significant. Introduction & Objectives: Radiotherapy is a proven treatment strategy for many forms of cancer. However, even successful treatment is associated with side effects and complications that may need Urological treatment. The aim of this study is to assess all admissions related to the side effects of radiotherapy to our institution, and report the treatments required and the burden these complications place on the healthcare system. Methods: All patients admitted, both emergency and elective, to our institution over a six-month period with a complication due to radiotherapy were assessed prospectively. Non-identifiable data was collected from medical records, including age, sex, co-morbidities, radiotherapy indication, time and dose of radiotherapy, complication type and treatment required. Results: The total number of admissions is 1198 patients, 921 of which were elective and 277 were emergency. 40 (3.33%) of total admissions were related to radiotherapy complications, 20 (50%) of these admissions were elective and 20 (50%) via emergency. Radiotherapy complications made up 2.1% of elective admissions, and 7.22% of emergency admissions. 26 patients (24 male, 2 female) accounted for these 40 admissions. 46 complications of radiotherapy were found in the 26 patients (Table 1 ). The most common complication was radiation cystitis (43.5%), followed by strictures (19.5%) and fistulas (10.9%). 73.9% of these complications needed surgical intervention while non-operative management was possible in 26.1%. The total bed days for these 40 admissions were 239, 17 (7.1%) of which were ICU bed days. Conclusions: At our institution, radiotherapy complications made up 3.3% of total admissions and 7.7% of our emergency admissions. Over 70% of these complications needed surgical intervention. The side effects of radiotherapy are considerable and account for a significant portion of the workload in our department.
Rare variants of type 1 papillary RCC: a double case series Introduction & Objectives: Papillary renal cell carcinoma (RCC) has traditionally been divided into Types 1 and 2, with well recognised differences in morphology and clinical behaviour. Recently, there have been small series of cases with variant morphology, and rare subcategories of papillary RCC are now being internationally recognised and reported. Oncocytic papillary RCC is typically regarded as a variant of Type 1 papillary RCC with its own distinct morphology, but its behaviour and prognosis is similar to Type 1 papillary RCC. Biphasic alveolar squamous (BAS) RCC has recently been described as another variant of Type 1 papillary RCC. This tumour has a distinct morphology and immunoprofile and is associated with a high incidence of second renal cancers. We report a small series of cases for both oncocytic papillary RCC and BAS RCC. Methods: We conducted a search through our databases for cases of both of the tumours described, and retrospectively collected general, oncological and histopathological data from the cases involved.
Results: In total we describe 4 cases of oncocytic papillary RCC and 5 cases of BAS RCC. Of the five cases of BAS RCC presented, two patients had additional cancers and one of these patients had BirtHogg-Dube syndrome. Prognosis is uncertain, but these tumours may behave aggressively. Conclusions: Oncocytic papillary RCC and BAS RCC are both rare variants of Type 1 papillary RCC. Larger case series are required to further understand these rare tumours, the way they behave and their subsequent phenotypical patterns.
Impact of adjuvant treatment on long-term quality of life in testicular cancer survivors
Introduction & Objectives: Issues of survivorship of testicular cancer are emerging due to excellent results from treatment. Treatment generally consists of orchidectomy followed by active surveillance or adjuvant therapy with chemotherapy, radiotherapy or retroperitoneal lymph node dissection. The 10-year overall survival rate for testicular cancer is 95%. The objectives of this project are to determine the effects of adjuvant therapy, education, cancer stage and age of diagnosis on longterm quality of life in testicular cancer survivors. N; Number. IQR; Interquartile range. %; percentage potentially improving patient outcomes. Despite its name, prostate specific membrane antigen (PSMA) has been shown to be highly expressed in the neovasculature of clear cell renal tumours and can be detected with positron emission tomography (PET) using novel inhibitors of PSMA.
In this ongoing pilot study, we review the utility of PSMA expression in staging RCC patients with advanced and metastatic disease. Methods: Twenty-five patients with advanced renal cell carcinoma were radiologically staged using standard imaging (computer tomography (CT), ultrasound, bone scan, magnetic resonance imaging (MRI)) as well as a 68-Gallium PSMA PET. Seventeen patients had primary renal tumour with local invasion or inferior vena cava extension (stage T3 or T4), whilst eight patients had metastatic disease. In twenty-one patients, histopathological tissue was available for correlation. Results: In all 25 patients primary and putative metastatic lesions were identified as PSMA PET avid with the degree of avidity and SUVmax being predominantly elevated in patients with metastatic disease and radiological evidence of vascular involvement. When comparing standard contrast CT images to PSMA PET images, a significantly larger proportion of lesions were identified using PET, altering management approaches for nine patients (36%, n = 9/25). Where histopathological correlation was available, 100% of PET avid lesions (n = 47) were concordant with renal cell carcinoma on histology. Conclusions: The identification of PSMA avidity in the neovasculature of clear cell renal cell carcinoma foci shows promise as a new tool in the radiological assessment of RCC particularly in the setting of advanced disease. Improvements in staging can translate to altered surgical or medical approaches for a particular patient and potentially to improved disease outcomes for all. Introduction: Multiparametric magnetic resonance imaging (mpMRI) and prostate specific membrane antigen positron emission tomography (PSMA PET) have been shown to demonstrate intraprostatic tumor with high contrast and detection rate in patients undergoing surgery. In this study, we identify localized prostate cancer using hybrid PSMA PET/MRI using wholemount prostate as a reference. Material and Methods: In a prospective pilot clinical trial, 10 patients who were suitable for surgical management of localized prostate cancer were recruited. All patients underwent PSMA PET/CT and hybrid PSMA PET/MRI pre-operatively. The results were separated as PET/CT, mpMRI and hybrid PSMA PET/MRI. The images were reported in European Society of Urogenital Radiology (ESUR) format by three separate experts who were blinded to other radiological or histopathological reports. Resected prostate specimens were assessed using whole-mount histopathological analysis. Reported radiological and histopathological segments were compared for segmental analysis (n = 243). Results: From 9 patients (1 excluded due to a metastatic lesion on PSMA PET/CT), 33 lesions were identified, of which 20 were clinically significant. mpMRI detected 10 lesions (segmental analysis -sensitivity, specificity, PPV and NPV = 33.87%, 93.37%, 63.64% and 80.48%) and PSMA PET/CT detected 12 lesions with 1 false positive (segmental analysis -sensitivity, specificity, PPV and NPV = 40.32%, 80.11%, 40.98% and 79.67%). Hybrid PSMA PET/MRI was then used to detect tumour with definition for prostate cancer being PI-RADS 3-5 and/or SUVmax greater than 1.5. 12 lesions were identified, however, with 2 false positives. Using segmental analysis, sensitivity, specificity, PPV and NPV were 27.42%, 99.45%, 94.44% and 80% respectively. Conclusions: In this prospective clinical trial, using the PI-RADS and PET reporting criteria, positive predictive and negative predictive values were substantially improved using hybrid PSMA PET/MRI in comparison to PET/CT or mpMRI alone. Larger study and case series are required to validate the results. Methods: Twenty-seven patients with histologically proven penile SCC underwent bilateral conventional lymphoscintigraphy and SPECT/CT from 2012-2106. In four patients, SPECT/CT identified a unilateral draining node basin despite palpable lymphadenopathy. These patients underwent bilateral dynamic sentinel lymph node biopsy and the pattern of contralateral lymphatic rerouting by tumor blockage was evaluated. Results: On the CT images, the palpable node metastases could be identified in all 4 groins. None of these groins demonstrated uptake of radioactivity on SPECT/ CT and rerouting of lymphatic drainage to the contralateral groin was observed. Tissue pathology of the excised radiolucent nodes demonstrated that inflammation (n = 1) sarcoidosis (N = 1) and metastasis (n = 2) were responsible for lymphatic rerouting. Conclusions: The concept of tumor blockage and rerouting was visualized in 15% of the groins who underwent SPECT/ CT. Precise physical examination and preoperative ultrasound with fine-needle aspiration cytology may identify nodes with considerable tumor invasion at an earlier stage and thereby reduce the incidence of false-negative results. Human factors like the presence of heterophile antibodies and choice of assay by the pathologist have been shown to affect PSA levels. Little is known about which handling and processing factors affect PSA levels and whether they differ among Australian pathologists. Methods: After ethics approval, we consented and enrolled 12 patients with a PSA level between 0.01 to 0.1 ng/ml post radical prostatectomy.
Three pathology laboratories;Laverty (LAV), Douglass Hanly Moir (DHM) and Healthscope (HSC) were used for sample processing with LAV as our reference laboratory. Six blood samples were collected per patient and handled as follows:: Three blood samples were sent to three different pathology laboratories for immediate processing. One sample was shaken vigorously for 5 minutes to achieve hemolysis then sent for immediate processing at LAV. One sample was stored overnight in a fridge at 4 degrees centigrade and another overnight at room temperature then processed the next day by LAV.
Differences in the mean reported PSA values (all in ng/ml) was analysed using SPSS version 8.0. Students T-test was used to compare the difference in means. Results: 12 patients were enrolled into the study with 11 patients included in the final analysis. The results of one patient were omitted from the final analysis since they were all reported as <0.01.
The mean PSA levels reported by the three different pathologists were; Laverty: 0.035, Healthscope: 0.044,Douglass Hanly Moir: 0.042. There was a significant difference between LAV and HSC (P = 0.02), LAV and DHM (P = 0.012), HSC and DHM (P = 0.033).
The mean PSA value for immediately processed samples was 0.035. When this was compared with the mean PSA value in haemolysed blood (0.035), blood stored overnight at 5 degrees centigrade (0.035) and blood stored at room temperature (0.039), no significant difference was detected (all P > 0.05). Conclusions: Different pathology labs provide different PSA levels. It is therefore imperative that the same pathologist is used consistently for PSA level testing. Hemolysis and varying overnight storage conditions did not affect the mean PSA results obviating the need for overnight cold storage of blood samples prior to PSA testing.
Urothelial malignancy register: no more cracks in the system
A. PATEL* , † , R. AKBAR* and J. PATERDIS* Introduction & Objectives: Losing patients to follow up in the Public hospital system is a fear of every clinical unit. Bladder malignancy surveillance requires tight monitoring for many years due to high rates of recurrence. Between outpatient flexible cystoscopies, rigid cystoscopic assessment or tumour resections in theatre, courses of intravesical therapies, and outpatient clinic follow up -there are many opportunities for patients to inadvertently miss surveillance checks, have clinic appointments delayed and even be lost to follow up. A register was constructed, in order to optimize appropriate follow up. Methods: Literature review was conducted using Embase, Medline / Pubmed using the keywords Malignancy, cancer, register, database, follow-up, and surveillance. Abstracts were screened for appropriateness, and articles were reviewed. No previous similar study with process analysis has been described. A web-based intranet database was constructed with all patients with urothelial malignancy known to our department being manually entered. URN codes were linked with the hospital administration system to allow auto-population of demographic information within the database. Information of dates and types of clinical interaction (clinic, OPD flexible cystoscopy or theatre procedures), are documented, along with findings and planned follow up. This follow up plan prompts reminders to ensure that follow up is booked and attended -this is also auto-populated from the hospital system. New cases are identified by a clinical nurse coordinator screening all flexible cystoscopies, theatre case audit, and the Histology Register (a tool used to ensure all histology is reviewed by a consultant clinician and communicated with the patient).
In real-time, a snapshot of patients awaiting appointment booking or late for timely follow up are able to be reviewed. Results: 538 patients on our surveillance program are all accounted for with appropriate follow up. Patients discharged from system have either deceased, discharged for alternative medical reasons, have been privately followed up, or have self-discharged. Conclusions: Using this application, with multimodal screening and regular database keeping, we have been able to efficiently maintain a clinically relevant urothelial malignancy register with no loss to follow up, ensuring patient safety with timely surveillance.
Neo active surveillance: initial biopsy avoidance and follow-up of men with negative MPMRI Introduction & Objective: Emerging evidence supports the use of mpMRI to help triage for prostate biopsy when reported by expert radiologists. Our previous report comparing mpMRI to transperineal biopsy showed that 26.5% of men with a negative mpMRI will have significant prostate cancer, the vast majority of whom have Grade Group 2 (Gleason 3 + 4 = 7) disease. Men with negative mpMRI and no biopsy therefore require close follow-up, a program we have termed Neo Active Surveillance (NAS). We aimed to determine the frequency of NAS in our group private practice.
Introduction & Objectives:
Transrectal biopsy is plagued by an increasing rate of serious infection, despite use of recommended fluoroquinolone antibiotics. Transperineal biopsy (TPB), on the other hand, has been associated with an exceedingly low rate of serious infection. The aim of this study was to determine the rate of hospital admissions for infection after transperineal biopsy of prostate. Methods: Patients underwent transperineal biopsy of the prostate (TPB) between May 2012 and June 2016 by a private group urology practice, at multiple hospitals across Melbourne. A standard brachytherapy template grid was used, taking a number of samples from left and right prostate posterior, mid and anterior regions. Some patients had extra core biopsies taken from target areas suspicious of cancer identified on prior MRI. Data collected from these patients were entered into an ethics approved prospective database including prophylactic antibiotics used and post operative complications. Results: 1,194 consecutive patients underwent TPB. Initially patients were treated with quinolone prophylaxis and then later patients received cephazolin only. 710 (59.5%) had single dose IV cephazolin, 388 (32.5%) had an oral quinolone, 92 (7.7%) had IV ceftriaxone and 4 (0.3%) had IV clindamycin or vancomycin prophylaxis. Routine practice shifted from use of quinolones to cephazolin during the study period. 21 (1.8%) patients developed acute urinary retention and 1 patient was treated in the community with oral antibiotics for prostatitis. No patients were readmitted to hospital with infection. Conclusions: Sepsis post TPB is an exceedingly rare complication, with a 0% rate in this large prospective multicentre cohort. It is safe to use single dose cephazolin only as antibiotic prophylaxis prior to TPB, negating the need for quinolones. This study supports the current Australian Therapeutic Guidelines recommendation for TPB prophylaxis. Whether any antibiotic prophylaxis is needed at all for TPB is the subject of a future study.
A retrospective analysis of transperineal cognitive fusion biopsy of high grade multiparametric MRI lesions compared with template mapping biopsies for diagnosis of clinically significant prostate cancer in a public tertiary hospital Introduction and Objectives: Multiparametric magnetic resonance imaging (mpMRI) of the prostate is widely used to guide biopsy in order to detect clinically significant prostate cancer (csPCa). We sought to evaluate mpMRI-based detection of csPCa in a public teaching urology unit and compare detection rates between transperineal cognitive fusion biopsy of suspicious MRI lesions against mapping biopsies. Methods: All patients subject to prostate mpMRI at the Royal Brisbane and Women's Hospital between 1 st July 2014 and 1 st July 2016 were considered for inclusion. Clinical data was collected including serum prostate specific antigen (PSA), prostate volume (per MRI estimate), PSA density, mpMRI PIRADS score, number of needle biopsies and biopsy histology reported according to ISUP guidelines. Results: 86 patients proceeded to transperineal prostate biopsy (TPPB) following a PIRADS score of 4 or 5, with 43 patients in each group. Patients with PIR-ADS 5 lesions demonstrated a higher median serum PSA (9.9, 6.4 ng/ml), PSA density (0.24, 0.17 ng/ml/cm 3 ), cancer diagnosis rate (96%, 81%) and biopsy grade (ISUP 3, ISUP 2). 22 PIRADS 5 patients and 21 PIRADS 4 patients had both template and cognitively targeted biopsies taken. The remaining had either template biopsies only (37) or target biopsies only (6). Of those who had both template and targeted biopsies, 21 (95.5%) and 20 (95.2%) patients from PIRADS 5 and 4 respectively demonstrated target lesions with higher Gleason score than template lesions. Conclusions: Transperineal biopsy with cognitive targeting in patients with PIR-ADS 4 and 5 lesions was highly accurate and improved in comparison to international data in detecting clinically significant prostate cancer. These data suggest that mp-MRI based csPCa detection is feasible in the public teaching setting.
Focal Irreversible Electroporation (IRE) as a primary and salvage treatment for localised prostate cancer AEs occurred. No significant differences were observed between baseline and 6 months for all QoL outcome domains across both treatment groups, except in the EPIC sexual function score, which showed a modest decline. Based on follow-up biopsy and/or MRI for selected primary focal therapy candidates, in-field freedom from clinically significant cancer was 88.7% (versus 83.0% for the wholegland). In the salvage treatment group, in-field freedom from clinically significant cancer was 92.3% (versus 76.9% for the whole-gland). Conclusions: IRE is an emerging therapy aiming to treat focal PCa with minimal impact on genitourinary functional outcomes. Our data supports the safety and feasibility of IRE use in both a primary and salvage setting. Further multi-centre prospective trials with longer follow-up are warranted to validate these results.
A comparison of the incidence of newly diagnosed metastatic prostate cancer at an Australian tertiary facility pre and post publication of the US Preventative Services Task Force (USPSTF) recommendation on PSA testing S. SMITH Townsville Hospital, Douglas, Australia Introduction & Objectives: Currently prostate specific antigen (PSA) screening remains a highly controversial topic within the medical profession. The USPSTF recommendation published in May 2012, changed the recommendation of PSA screening to that of Category D (moderate or high certainty that the service has no benefit or that the harms outweigh the benefits). Subsequently, the Australian College of General Practitioners changed their guidelines recommending against population based PSA screening. The aim of this study is to test the hypothesis that the incidence of metastatic disease in newly diagnosed prostate cancer has increased post changes to the PSA screening guidelines. Methods: A retrospective analysis was undertaken of patients who had been newly diagnosed with prostate cancer on transrectal ultrasound (TRUS) biopsy at the Townsville Hospital between 2009 and 2015. Patients were divided into two groups based on when they had undergone their TRUS biopsy either pre (2009-2011) or post (2013-2015) release of the USPSTF recommendations on PSA screening. Metastatic disease status was determined by reviewing both a CT chest, abdomen and pelvis as well as a nuclear medicine bone scan that each patient had undergone as part of their disease staging workup. A comparison of the incidence of newly diagnosed metastatic prostate cancer was then made between the two groups. Results: One hundred and thirty patients were allocated to each group. In the pre USPSTF guidelines group, twenty-three out of one hundred and thirty patients had newly diagnosed metastatic prostatic cancer (17.7%). In comparison, forty-one out of one hundred and thirty patients (31.5%) had newly diagnosed metastatic prostate cancer in the post USPSTF guidelines group. Conclusions: Alarmingly, the incidence of newly diagnosed metastatic prostate cancer nearly doubled in patients referred to the Urology Department at the Townsville Hospital post the release of the USPSTF guidelines in 2012. This data is suggestive that a correlation exists between altered PSA screening guidelines and the incidence of newly diagnosed metastatic prostate cancer within the Australian setting.
Patterns of failure in a prospective pilot study of Oligometastases from prostate cancer treated with Stereotactic Ablative Radiosurgery (POPSTAR)
Female gender is associated with
